Pyoderma gangrenosum in Sjögren's syndrome and its successful treatment with topical application of etanercept

Int J Rheum Dis. 2017 May;20(5):657-659. doi: 10.1111/1756-185X.13086. Epub 2017 Apr 17.

Authors

Vikram Haridas^{1

2}, Praveenkumar Shetty³, Leonard C Dsouza³, U S Dinesh⁴, Kiran Haridas², Anil Bargale³

Affiliations

¹ Department of Medicine, SDM College of Medical Sciences & Hospital, Dharwad, Karnataka, India.
² Arthritis Superspeciality Center, Hubli, Karnataka, India.
³ Central Research Laboratory and Department of Biochemistry, SDM College of Medical Sciences & Hospital, Dharwad, Karnataka, India.
⁴ Department of Pathology, SDM College of Medical Sciences & Hospital, Dharwad, Karnataka, India.

PMID: 28419761
DOI: 10.1111/1756-185X.13086

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Biopsy
Etanercept / therapeutic use*
Female
Humans
Immunohistochemistry
Immunosuppressive Agents / therapeutic use*
Pyoderma Gangrenosum / diagnosis
Pyoderma Gangrenosum / drug therapy*
Pyoderma Gangrenosum / immunology
Sjogren's Syndrome / complications
Sjogren's Syndrome / diagnosis
Sjogren's Syndrome / drug therapy*
Sjogren's Syndrome / immunology
Skin / drug effects*
Skin / immunology
Skin / pathology
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Tumor Necrosis Factor-alpha / immunology
Wound Healing / drug effects

Substances

Immunosuppressive Agents
Tumor Necrosis Factor-alpha
Etanercept